Table 2.
Effects of ischemia-reperfusion and PPC on cardiac enzymes levels.
| Treatment | CK IU/L | P value | LDH IU/L | P value |
|---|---|---|---|---|
| Ctr male | 21.32 ± 1.84 | — | 20.73 ± 1.37 | — |
| Ctr male + PPC | 9.41 ± 1.87∗ | 0.001 | 7.94 ± 1.83∗ | 0.001 |
| Ctr old male | 21.13 ± 1.12 | — | 18.62 ± 2.10 | — |
| Old male + PPC | 20.23 ± 1.43 | 0.231 | 18.42 ± 2.02 | 0.411 |
| Ctr female | 20.13 ± 1.82 | — | 18.93 ± 1.11 | — |
| Ctr female + PPC | 10.21 ± 1.71∗ | 0.001 | 9.95 ± 1.64∗ | 0.001 |
| Ctr old female | 20.13 ± 1.86 | — | 16.47 ± 1.82 | — |
| Old female + PPC | 10.53 ± 1.24∗ | 0.001 | 9.03 ± 1.65∗ | 0.001 |
| Ctr male | 23.41 ± 2.13 | — | 19.21 ± 1.98 | — |
| Ctr male + PPC | 10.23 ± 1.43∗ | 0.001 | 8.11 ± 2.13∗ | 0.001 |
| Ctr LVH male | 23.54 ± 2.63 | — | 16.22 ± 1.43 | — |
| LVH male + PPC | 21.39 ± 2.02 | 0.315 | 17.53 ± 1.45 | 0.314 |
| Ctr female | 20.85 ± 1.93 | — | 17.97 ± 1.36 | — |
| Ctr female + PPC | 10.98 ± 1.61∗ | 0.001 | 9.14 ± 1.82∗ | 0.001 |
| Ctr LVH female | 22.10 ± 1.83 | — | 16.31 ± 1.92 | — |
| LVH female + PPC | 9.14 ± 1.19∗ | 0.001 | 10.63 ± 1.92∗ | 0.01 |
| Ctr diabetic male | 23.75 ± 2.13 | — | 17.52 ± 1.61 | — |
| Diabetic male + PPC | 21.72 ± 1.71 | 0.524 | 19.27 ± 2.13 | 0.243 |
| Ctr diabetic female | 20.63 ± 2.85 | — | 18.92 ± 1.62 | — |
| Diabetic female + PPC | 21.31 ± 1.86 | 0.463 | 18.26 ± 1.23 | 0.217 |
| Ctr female 19 GD | 20.42 ± 1.66 | — | 16.24 ± 1.23 | — |
| Female 19 GD + PPC | 9.92 ± 1.12∗ | 0.001 | 8.31 ± 1.14∗ | 0.001 |
| Ctr female 21 GD | 21.33 ± 1.62 | — | 17.24 ± 1.38 | — |
| Female 21 GD + PPC | 9.87 ± 1.95∗ | 0.001 | 8.05 ± 1.23∗ | 0.001 |
CK: creatine kinase; LDH: lactate dehydrogenase; Ctr: control; PPC: pacing postconditioning; LVH: left ventricle hypertrophy; GD: gestation day. ∗P < 0.001 compared to the respective control.